Home  /  Resource Library  /  Zanubrutinib versus fludarabine, cyclophosphamide and rituximab in fit, treatment-naive patients with chronic lymphocytic leukemia: a matching-adjusted indirect comparison

Zanubrutinib versus fludarabine, cyclophosphamide and rituximab in fit, treatment-naive patients with chronic lymphocytic leukemia: a matching-adjusted indirect comparison

Indirect comparison of zanubrutinib versus FCR for first line treatment of CLL.